Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

View:
Post by Lesalpes29 on Jun 06, 2023 7:29am

Cool!

Dr. Lbiati is an internationally trained medical doctor, who utilizes her extensive clinical and business background to assist biopharmaceutical organizations to achieve their strategic objectives through: systematic achievement of their value inflection milestones, partnering of their promising drug candidates with large international pharmaceutical companies and ultimately increasing shareholder value.

An other indication that we are close to something good! GL
Comment by 99942Apophis on Jun 06, 2023 7:48am
This is surprisingly revealing to Theralase's plan in my opinion only to not only go into commercialization in Canada & US but internationally i.e. Europe perhaps Asia and other countries where Theralase has patents filed. It appears TLT might be looking for more than one partner to enter commercialization which makes perfect sense as no one single company will be able to use leverage ...more  
Comment by thadeush on Jun 06, 2023 8:25am
Agreed. I also like the word, "firstly." "Canadian-born Anti-Cancer Therapy ("ACT") is on the verge of demonstrating to the world the safety and efficacy that this platform truly bring to patients inflicted with cancer; firstly for patients diagnosed with Bacillus Calmette-Gurin ("BCG")..." More to come
Comment by Oilminerdeluxe on Jun 06, 2023 8:35am
Interersting. Time for some action perhaps. Now please get that BTD approval for a starters and some fresh money in the till and off to the races we go.
Comment by Rumpl3StiltSkin on Jun 06, 2023 9:04am
Great!  RW being back bodes well for that. And now this new appointment... Seem BTD application should happen soon. Followed by a solid JV. :-)
Comment by jicoop on Jun 06, 2023 9:40am
Not quite the news I've been waiting for all these years, but positive and encouraging nonetheless. Fingers and toes still crossed that this goes all the way. Coop
Comment by gordo323 on Jun 06, 2023 10:19am
INTERNATIONAL POLICY DIGEST WORLD POLITICS U.S. NEWS ENTERTAINMENT TECH SCIENCE HEALTH MEDIA CULTURE BOOKS BUSINESS    ...more  
Comment by Oilminerdeluxe on Jun 06, 2023 10:25am
Vera 2.0? 
Comment by DJDawg on Jun 06, 2023 10:29am
That is funny. That is has to be the most inside joke for TLT I've ever seen. Well played.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250